Analytical Data
-
Gene name
SBK3
- Application
-
Alternative Names
SBK3; Uncharacterized serine/threonine-protein kinase SBK3; SH3-binding domain kinase family member 3; Sugen kinase 110
-
Species
Human
-
Source
Baculovirus
-
Tag
N-8*His;N-GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0C264
-
Expression Region
E2-P359
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SBK3 (Serine/Threonine-protein kinase 3) is a member of the Ste20-like kinase family, which plays a pivotal role in various cellular processes, including cell proliferation, apoptosis, and differentiation. Research into SBK3 has gained significant attention due to its involvement in multiple signaling pathways that affect tumorigenesis and immune response. Recent studies have identified SBK3 as a key regulator in cancer biology, particularly in modulating the tumor microenvironment and influencing the efficacy of cancer therapies. Furthermore, the ability to modulate SBK3 activity presents promising therapeutic avenues for targeting malignancies and other diseases characterized by aberrant signaling pathways. The reconstitution of SBK3 protein in experimental models is essential for elucidating its functional mechanisms and exploring its potential as a biomarker or therapeutic target. Scientists aim to understand how SBK3 interacts with other proteins and signaling molecules, which could lead to novel strategies for disease intervention. As research progresses, the continued exploration of SBK3's roles in health and disease may unveil critical insights into its biological significance and therapeutic potential.
